Gaps and opportunities in sepsis translational research

Majno, 1991, The ancient riddle of (Sepsis), J Infect Dis, 163, 937, 10.1093/infdis/163.5.937 1972 Leligdowicz, 2022, Immune modulation in sepsis, ARDS, and Covid-19 — the road traveled and the road ahead, NEJM EEvidence, 1 Bone, 1992, ACCP/SCCM CONSENSUS CONFERENCE. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Chest, 101, 1644, 10.1378/chest.101.6.1644 Singer, 2016, The third international consensus definitions for sepsis and septic shock (Sepsis-3), JAMA, 315, 801, 10.1001/jama.2016.0287 Marshall, 1990, Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome, Arch Surg, 125, 17, 10.1001/archsurg.1990.01410130019002 Lynch, 2016, The human intestinal microbiome in health and disease, N Engl J Med, 375, 2369, 10.1056/NEJMra1600266 Schmidt, 2018, The human gut microbiome: from association to modulation, Cell, 172, 1198, 10.1016/j.cell.2018.02.044 Belkaid, 2014, Role of the microbiota in immunity and inflammation, Cell, 157, 121, 10.1016/j.cell.2014.03.011 Vijay, 2018, Toll-like receptors in immunity and inflammatory diseases: past, present, and future, Int Immunopharmacol, 59, 391, 10.1016/j.intimp.2018.03.002 Calvano, 2005, A network-based analysis of systemic inflammation in humans, Nature, 437, 1032, 10.1038/nature03985 Taveira Da Silva, 1993, Brief report: shock and multiple organ dysfunction after self administration of salmonella endotoxin, N Engl J Med, 328, 1457, 10.1056/NEJM199305203282005 Marshall, 2014, Why have clinical trials in sepsis failed?, Trends Mol Med, 20, 195, 10.1016/j.molmed.2014.01.007 Fang, 2019, Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis, JAMA Intern Med, 179, 213, 10.1001/jamainternmed.2018.5849 Antcliffe, 2019, Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial, Am J Respir Crit Care Med, 199, 980, 10.1164/rccm.201807-1419OC Sterne, 2020, Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis, JAMA, 324, 1330, 10.1001/jama.2020.17023 Chaudhuri, 2021, Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis, Intensive Care Med, 47, 521, 10.1007/s00134-021-06394-2 Ziegler, 1991, Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin, N Engl J Med, 324, 429, 10.1056/NEJM199102143240701 Opal, 2013, Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial, JAMA, 309, 1154, 10.1001/jama.2013.2194 Bone, 1995, A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial, Crit Care Med, 23, 994, 10.1097/00003246-199506000-00003 Marshall, 2004, Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study, J Infect Dis, 190, 527, 10.1086/422254 Charbonney, 2016, Endotoxemia following multiple trauma: risk factors and prognostic implications, Crit Care Med, 44, 335, 10.1097/CCM.0000000000001404 Klein, 2011, Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: a prospective observational study, Crit Care, 15, R69, 10.1186/cc10051 Beutler, 1985, Passive immunization against cachectin tumor necrosis factor protects mice from lethal effect of endotoxin, Science, 229, 869, 10.1126/science.3895437 Palladino, 2003, Anti-TNF-alpha therapies: the next generation, Nat Rev Drug Discov, 2, 736, 10.1038/nrd1175 Dinarello, 1993, The role of interleukin-1 in disease, N Engl J Med, 328, 106, 10.1056/NEJM199301143280207 Shakoory, 2016, Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial, Crit Care Med, 44, 275, 10.1097/CCM.0000000000001402 Kyriazopoulou, 2021, Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial, Nat Med, 27, 1752, 10.1038/s41591-021-01499-z Nikfar, 2018, Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis, Rheumatol Int, 38, 1363, 10.1007/s00296-018-4041-1 Gordon, 2021, Interleukin-6 receptor antagonists in critically ill patients with Covid-19, N Engl J Med, 384, 1491, 10.1056/NEJMoa2100433 Shankar-Hari, 2021, Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis, JAMA, 326, 499, 10.1001/jama.2021.11330 Tanaka, 2018, Interleukin (IL-6) immunotherapy, Cold Spring Harb Perspect Biol, 10, 10.1101/cshperspect.a028456 Bernard, 2001, Efficacy and safety of recombinant human activated protein C for severe sepsis, N Engl J Med, 344, 699, 10.1056/NEJM200103083441001 Ranieri, 2012, Drotrecogin alfa (activated) in adults with septic shock, N Engl J Med, 366, 2055, 10.1056/NEJMoa1202290 Abraham, 2003, Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial, JAMA, 290, 238, 10.1001/jama.290.2.238 Warren, 2001, High-dose antithrombin III in severe sepsis: a randomized, controlled trial, JAMA, 286, 1869, 10.1001/jama.286.15.1869 Vincent, 2019, Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial, JAMA, 321, 1993, 10.1001/jama.2019.5358 ATTACC Investigators, 2021, Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19, N Engl J Med, 385, 790, 10.1056/NEJMoa2105911 Bradbury, 2022, Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial, JAMA, 327, 1247, 10.1001/jama.2022.2910 Group, 2022, Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis, Lancet, 400, 359, 10.1016/S0140-6736(22)01109-6 Guimaraes, 2021, Tofacitinib in patients hospitalized with Covid-19 pneumonia, N Engl J Med, 385, 406, 10.1056/NEJMoa2101643 Tanaka, 2022, Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach, Nat Rev Rheumatol, 18, 133, 10.1038/s41584-021-00726-8 Sibbald, 1976, Sepsis--the Wayne State University Symposium--part III. Bacteremia and endotoxemia: a discussion of their roles in the pathophysiology of gram-negative sepsis, Heart Lung, 5, 765 Meakins, 1980, The surgical intensive care unit: current concepts in infection, Surg Clin North Am, 60, 117, 10.1016/S0039-6109(16)42038-4 Maclean, 1967, Patterns of septic shock in man - a detailed study of 56 patients, Ann Surg, 166, 543, 10.1097/00000658-196710000-00004 Ashbaugh, 1967, Acute respiratory distress in adults, Lancet, 2, 319, 10.1016/S0140-6736(67)90168-7 Baue, 1975, Multiple, progressive, or sequential systems failure. A syndrome of the 1970s, Arch Surg, 110, 779, 10.1001/archsurg.1975.01360130011001 Bone, 1989, Sepsis syndrome: a valid clinical entity, Crit Care Med, 17, 389, 10.1097/00003246-198905000-00002 Medzhitov, 2002, Decoding the patterns of self and nonself by the innate immune system, Science, 296, 298, 10.1126/science.1068883 Schuurman, 2021, Sepsis: deriving biological meaning and clinical applications from high-dimensional data, Intensive Care Med Exp, 9, 27, 10.1186/s40635-021-00383-x Cercek, 2022, PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer, N Engl J Med, 386, 2363, 10.1056/NEJMoa2201445 Marshall, 2009, Biomarkers of sepsis, Crit Care Med, 37, 2290, 10.1097/CCM.0b013e3181a02afc Ebell, 2020, Accuracy of biomarkers for the diagnosis of adult community-acquired pneumonia: a meta-analysis, Acad Emerg Med, 27, 195, 10.1111/acem.13889 Pierrakos, 2020, Biomarkers of sepsis: time for a reappraisal, Crit Care, 24, 287, 10.1186/s13054-020-02993-5 Lukaszewski, 2022, Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures, Intensive Care Med, 48, 1133, 10.1007/s00134-022-06769-z Panacek, 2004, Efficacy and safety of the monoclonal anti-TNF antibody F(ab')2 fragment in patients with severe sepsis stratified by IL-6 level, Crit Care Med, 32, 2173, 10.1097/01.CCM.0000145229.59014.6C Dellinger, 2018, Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial, JAMA, 320, 1455, 10.1001/jama.2018.14618 Levi, 2020, Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy, Crit Care Med, 48, 1140, 10.1097/CCM.0000000000004426 Berry, 2015, The platform trial: an efficient strategy for evaluating multiple treatments, JAMA, 313, 1619, 10.1001/jama.2015.2316 Group, 2021, Dexamethasone in hospitalized patients with Covid-19, N Engl J Med, 384, 693, 10.1056/NEJMoa2021436 Angus, 2020, Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial, JAMA, 324, 1317, 10.1001/jama.2020.17022 Investigators, 2021, Interleukin-6 receptor antagonists in critically ill patients with Covid-19, N Engl J Med, 384, 1491, 10.1056/NEJMoa2100433 Park, 2016, Adaptive randomization of neratinib in early breast cancer, N Engl J Med, 375, 11, 10.1056/NEJMoa1513750 Woodcock, 2017, Master protocols to study multiple therapies, multiple diseases, or both, N Engl J Med, 377, 62, 10.1056/NEJMra1510062 Park, 2019, Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols, Trials, 20, 572, 10.1186/s13063-019-3664-1 Sorenson, 1988, Genetic and environmental influences on premature death in adult adoptees, N Engl J Med, 318, 727, 10.1056/NEJM198803243181202 Emdin, 2017, Mendelian randomization, JAMA, 318, 1925, 10.1001/jama.2017.17219 Marshall, 2001, Effect of anti-TNF antibody on organ-specific components of MOD score, Am J Resp Crit Care Med, 163, A820 Calfee, 2018, Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial, Lancet Respir Med, 6, 691, 10.1016/S2213-2600(18)30177-2 Shah, 2021, A research agenda for precision medicine in sepsis and acute respiratory distress syndrome: an official American thoracic society research statement, Am J Respir Crit Care Med, 204, 891, 10.1164/rccm.202108-1908ST Calfee, 2014, Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials, Lancet Respir Med, 2, 611, 10.1016/S2213-2600(14)70097-9 Iwashyna, 2015, Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care, Am J Respir Crit Care Med, 192, 1045, 10.1164/rccm.201411-2125CP Kent, 2018, Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects, BMJ, 363, k4245, 10.1136/bmj.k4245 Davenport, 2016, Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study, Lancet Respir Med, 4, 259, 10.1016/S2213-2600(16)00046-1 Scicluna, 2017, Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study, Lancet Respir Med, 5, 816, 10.1016/S2213-2600(17)30294-1 Seymour, 2019, Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis, JAMA, 321, 2003, 10.1001/jama.2019.5791 Angus, 2001, Incidence, cost, and outcome of severe sepsis in the United States, Crit Care Med, 29, 1303, 10.1097/00003246-200107000-00002 Mahmood, 2014, The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective, Lancet, 383, 999, 10.1016/S0140-6736(13)61752-3 Andersson, 2019, 70-year legacy of the Framingham heart study, Nat Rev Cardiol, 16, 687, 10.1038/s41569-019-0202-5 Gospodarowicz, 1998, History and international developments in cancer staging, Cancer Prev Cont, 2, 262 Brierley, 2006, The evolving TNM cancer staging system: an essential component of cancer care, CMAJ, 174, 155, 10.1503/cmaj.045113 The, 2021, 20 years of precision medicine in oncology, Lancet, 397, 1781, 10.1016/S0140-6736(21)01099-0 Group, 2021, The value of open-source clinical science in pandemic response: lessons from ISARIC, Lancet Infect Dis, 21, 1623, 10.1016/S1473-3099(21)00565-X Dunning, 2014, Open source clinical science for emerging infections, Lancet Infect Dis, 14, 8, 10.1016/S1473-3099(13)70327-X Pairo-Castineira, 2021, Genetic mechanisms of critical illness in COVID-19, Nature, 591, 92, 10.1038/s41586-020-03065-y 2021, Mapping the human genetic architecture of COVID-19, Nature, 600, 472, 10.1038/s41586-021-03767-x Kalil, 2021, Baricitinib plus remdesivir for hospitalized adults with Covid-19, N Engl J Med, 384, 795, 10.1056/NEJMoa2031994 Maslove, 2022, Redefining critical illness, Nat Med, 28, 1141, 10.1038/s41591-022-01843-x Horby, 2021, Dexamethasone in hospitalized patients with Covid-19 - preliminary report, N Engl J Med, 384, 693, 10.1056/NEJMoa2021436